Bordeaux PharmacoEpi, INSERM CIC1401, Université de BORDEAUX, France
I do not have any relevant financial / non-financial relationships with any proprietary interests.
OP-1D - Risk of Malignancies in Newly Treated Patients with Disease-modifying Drugs for Multiple Sclerosis: Assessment According to Cohort and Nested-case Control Approaches
Wednesday, August 25, 20214:30 PM – 6:00 PM US Eastern Time